Investments
2Portfolio Exits
1Expert Collections containing Apeiron Partners
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find Apeiron Partners in 1 Expert Collection, including Synthetic Biology.
Synthetic Biology
382 items
Apeiron Partners Investments
2 Investments
Apeiron Partners has made 2 investments. Their latest investment was in EnBiotix as part of their Series A on May 5, 2016.
Apeiron Partners Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
5/12/2016 | Series A | EnBiotix | Yes | 3 | ||
8/7/2006 | Series A |
Date | 5/12/2016 | 8/7/2006 |
|---|---|---|
Round | Series A | Series A |
Company | EnBiotix | |
Amount | ||
New? | Yes | |
Co-Investors | ||
Sources | 3 |
Apeiron Partners Portfolio Exits
1 Portfolio Exit
Apeiron Partners has 1 portfolio exit. Their latest portfolio exit was EnBiotix on December 30, 2021.
Apeiron Partners Team
1 Team Member
Apeiron Partners has 1 team member, including current Managing Director, Jeffrey D Wager.
Name | Work History | Title | Status |
|---|---|---|---|
Jeffrey D Wager | EnBiotix, Artisan Pharma, and Medical Science Partners | Managing Director | Current |
Name | Jeffrey D Wager |
|---|---|
Work History | EnBiotix, Artisan Pharma, and Medical Science Partners |
Title | Managing Director |
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.